Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Item
http://www.wikidata.org/entity/Q38393265
Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles.High Perforin-Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long-Term Mortality in Patients With Inflammatory Cardiomyopathy.Inflammation in Heart Failure: known knowns and unknown unknowns.Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature.High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection.Revealing enterovirus infection in chronic human disorders: An integrated diagnostic approach.Spontaneous activation of a MAVS-dependent antiviral signaling pathway determines high basal interferon-β expression in cardiac myocytes.[Inflammatory cardiomyopathy and myocarditis].Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.Age-Associated Changes in Estrogen Receptor Ratios Correlate with Increased Female Susceptibility to Coxsackievirus B3-Induced Myocarditis.Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy.T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral Therapies.Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulinsCCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5
P2860

Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Item
http://www.wikidata.org/entity/Q38393265
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Betaferon in chronic viral car ...... chronic viral cardiomyopathy.
@en
type
label
Betaferon in chronic viral car ...... chronic viral cardiomyopathy.
@en
prefLabel
Betaferon in chronic viral car ...... chronic viral cardiomyopathy.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Betaferon in chronic viral car ...... chronic viral cardiomyopathy.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698